Treatments · Entity Annotation Prototype (beta)

7articles mentioning treatments

9treatment mentions

1distinct treatments extracted

0%of mentions human-reviewed

Active filtersEntity: Endocrine therapy ×

Endocrine therapy

This treatment is selected. Its supporting articles are shown below.

Endocrine therapy7

Articles mentioning Endocrine therapy

7 articles · page 1 of 1

Impact of immunotherapy and small molecule cancer therapy on fertility: a narrative review of current evidence, mechanisms and future directions

bmjonc · full text · 2026-01-28 · 2 matching annotations

81.1%

chemotherapy Endocrine therapy CD30 CAR-T immunotherapy pembrolizumab bortezomib

… in both early-stage and metastatic settings when combined with chemotherapy. Poly (ADP-ribose) polymerase (PARP) inhibitors, particularly o…

Second cancers in 475 000 women with early invasive breast cancer diagnosed in England during 1993-2016: population based observational cohort study

bmj · abstract · 2025-08-27 · 2 matching annotations

83.7%

radiotherapy chemotherapy endocrine therapy contralateral breast cancer breast cancer contralateral breast cancers

…When patients were categorised according to adjuvant treatment, radiotherapy was associated with increased contralateral breast and lung can…

Effect of yoga on musculoskeletal complaints in women during endocrine treatment for breast cancer: protocol of the randomised controlled COBRA trial

bmjopen · abstract · 2026-06-09 · 1 matching annotations

96.4%

endocrine therapy endocrine therapy-associated Brief Pain Inventory breast cancer University Medical Center Utrecht NCT06480513

…Introduction Approximately 40% of women stop endocrine therapy for hormone-receptor-positive breast cancer within the first 5 …

4CPS-174 Effectiveness and safety of abemaciclib in women with hormone receptor-positive, her-2-negative metastatic breast cancer: results in routine clinical practice

ejhpharm · abstract · 2026-03-18 · 1 matching annotations

83.7%

endocrine therapy abemaciclib breast cancer ribociclib palbociclib fulvestrant Regional University Hospital of Málaga anastrozole letrozole

…tastatic disease over 20 years. CDK4/6 inhibitors combined with endocrine therapy have doubled progression-free survival. Approved agents include…

930 Discovery of immunogenic neo-peptides from actionable chimeric RNAs to develop personalized vaccines for breast cancer treatment

jitc · abstract · 2025-11-04 · 1 matching annotations

90.8%

endocrine therapy Breast cancer CDK4/6 inhibitors CDK 4/6 inhibitors XenoSTART World Health Organization CDK4/6

… Despite advances such as CDK4/6 inhibitors in combination with endocrine therapy for hormone receptor-positive (HR+) breast cancer, therapeutic …

931 Discovery of immunogenic neopeptides from actionable RNA fusion ESR1-PRKN for developing cancer vaccines

jitc · abstract · 2025-11-04 · 1 matching annotations

90.7%

endocrine therapy breast cancer CDK4/6 inhibitors CDK 4/6 inhibitors XenoSTART World Health Organization CDK4/6

… Despite advances such as CDK4/6 inhibitors in combination with endocrine therapy for hormone receptor-positive (HR+) breast cancer, therapeutic …

Cyclin-dependent kinase 4/6 inhibitor ribociclib-induced colitis with a successful transition to palbociclib

bmjcr · abstract · 2025-08-21 · 1 matching annotations

82.3%

endocrine therapy ribociclib Palbociclib letrozole human epidermal growth factor receptor 2-negative metastatic breast cancer Ribociclib-induced CDK4/6I

…inhibitors (CDK4/6Is), including ribociclib, are used alongside endocrine therapy for hormone receptor-positive (HR+) and human epidermal growth …